Literature DB >> 21531214

Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Katsuyuki Nakajima1, Takamitsu Nakano, Yoshiharu Tokita, Takeaki Nagamine, Akihiro Inazu, Junji Kobayashi, Hiroshi Mabuchi, Kimber L Stanhope, Peter J Havel, Mitsuyo Okazaki, Masumi Ai, Akira Tanaka.   

Abstract

Since Zilversmit first proposed postprandial lipemia as the most common risk of cardiovascular disease, chylomicrons (CM) and CM remnants have been thought to be the major lipoproteins which are increased in the postprandial hyperlipidemia. However, it has been shown over the last two decades that the major increase in the postprandial lipoproteins after food intake occurs in the very low density lipoprotein (VLDL) remnants (apoB-100 particles), not CM or CM remnants (apoB-48 particles). This finding was obtained using the following three analytical methods; isolation of remnant-like lipoprotein particles (RLP) with specific antibodies, separation and detection of lipoprotein subclasses by gel permeation HPLC and determination of apoB-48 in fractionated lipoproteins by a specific ELISA. The amount of the apoB-48 particles in the postprandial RLP is significantly less than the apoB-100 particles, and the particle sizes of apoB-48 and apoB-100 in RLP are very similar when analyzed by HPLC. Moreover, CM or CM remnants having a large amount of TG were not found in the postprandial RLP. Therefore, the major portion of the TG which is increased in the postprandial state is composed of VLDL remnants, which have been recognized as a significant risk for cardiovascular disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531214      PMCID: PMC3265327          DOI: 10.1016/j.cca.2011.04.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  110 in total

1.  A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay.

Authors:  K Nakajima; T Saito; A Tamura; M Suzuki; T Nakano; M Adachi; A Tanaka; N Tada; H Nakamura; T Murase
Journal:  J Atheroscler Thromb       Date:  1994       Impact factor: 4.928

2.  The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons.

Authors:  M Mochizuki; Y Takada; T Urano; N Nagai; T Nakano; K Nakajima; A Takada
Journal:  Thromb Res       Date:  1996-03-01       Impact factor: 3.944

3.  Postprandial lipaemia.

Authors:  J R Patsch
Journal:  Baillieres Clin Endocrinol Metab       Date:  1987-08

4.  Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma.

Authors:  A Ritsch; H Drexel; F W Amann; C Pfeifhofer; J R Patsch
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-12       Impact factor: 8.311

5.  Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study.

Authors:  J R McNamara; P K Shah; K Nakajima; L A Cupples; P W Wilson; J M Ordovas; E J Schaefer
Journal:  Clin Chem       Date:  1998-06       Impact factor: 8.327

6.  Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test.

Authors:  A Tanaka; N Tomie; T Nakano; K Nakajima; K Yui; M Tamura; F Numano
Journal:  Clin Chim Acta       Date:  1998-07-06       Impact factor: 3.786

7.  Triglyceride and coronary heart disease mortality in a 24-year follow-up study in Xi'an, China.

Authors:  Yao He; Tai Hing Lam; Lan Sun Li; Liang Shou Li; Shu Fang He; Bao Qing Liang
Journal:  Ann Epidemiol       Date:  2004-01       Impact factor: 3.797

8.  Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.

Authors:  C Marcoux; M Tremblay; A Fredenrich; H Jacques; L Krimbou; K Nakajima; J Davignon; J S Cohn
Journal:  Atherosclerosis       Date:  1998-07       Impact factor: 5.162

9.  A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load.

Authors:  Masumi Ai; Akira Tanaka; Kentaro Shimokado; Rumiko Ohtani; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Takamitsu Nakano; Katsuyuki Nakajima
Journal:  Ann Clin Biochem       Date:  2009-07-29       Impact factor: 2.057

Review 10.  Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.

Authors:  Samir S Deeb; Alberto Zambon; Molly C Carr; Amir F Ayyobi; John D Brunzell
Journal:  J Lipid Res       Date:  2003-03-16       Impact factor: 5.922

View more
  30 in total

1.  The ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fat.

Authors:  Tomomi Yamazaki; Kyoko Kishimoto; Osamu Ezaki
Journal:  J Lipid Res       Date:  2012-06-26       Impact factor: 5.922

Review 2.  Role of the gut in modulating lipoprotein metabolism.

Authors:  Alan A Hennessy; R Paul Ross; Gerald F Fitzgerald; Noel Caplice; Catherine Stanton
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Serum TG-lowering properties of plant sterols and stanols are associated with decreased hepatic VLDL secretion.

Authors:  Marleen Schonewille; Gemma Brufau; Ronit Shiri-Sverdlov; Albert K Groen; Jogchum Plat
Journal:  J Lipid Res       Date:  2014-10-27       Impact factor: 5.922

4.  Postprandial remodeling of high-density lipoprotein following high saturated fat and high carbohydrate meals.

Authors:  Michelle Averill; Katya B Rubinow; Kevin Cain; Jake Wimberger; Ilona Babenko; Jessica O Becker; Karen E Foster-Schubert; David E Cummings; Andrew N Hoofnagle; Tomas Vaisar
Journal:  J Clin Lipidol       Date:  2019-11-22       Impact factor: 4.766

5.  C1q/TNF-related protein 2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic triglyceride secretion.

Authors:  Xia Lei; G William Wong
Journal:  J Biol Chem       Date:  2019-08-22       Impact factor: 5.157

6.  Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Authors:  Zareen M Farukhi; Olga V Demler; Michael P Caulfield; Krishnaji Kulkarni; Jay Wohlgemuth; Michael Cobble; Heike Luttmann-Gibson; Chunying Li; John R Nelson; Nancy R Cook; Julie E Buring; Ronald M Krauss; JoAnn E Manson; Samia Mora
Journal:  J Clin Lipidol       Date:  2020-02-21       Impact factor: 4.766

Review 7.  Clinical considerations and mechanistic determinants of postprandial lipemia in older adults.

Authors:  Christos S Katsanos
Journal:  Adv Nutr       Date:  2014-05-14       Impact factor: 8.701

8.  Increased plasma availability of L-arginine in the postprandial period decreases the postprandial lipemia in older adults.

Authors:  Guilherme M Puga; Christian Meyer; Lawrence J Mandarino; Christos S Katsanos
Journal:  Nutrition       Date:  2012-09-06       Impact factor: 4.008

9.  Differential effects of low-fat and high-fat diets on fed-state hepatic triacylglycerol secretion, hepatic fatty acid profiles, and DGAT-1 protein expression in obese-prone Sprague-Dawley rats.

Authors:  Timothy D Heden; E Matthew Morris; Monica L Kearney; Tzu-Wen Liu; Young-Min Park; Jill A Kanaley; John P Thyfault
Journal:  Appl Physiol Nutr Metab       Date:  2013-11-15       Impact factor: 2.665

10.  Cholecystokinin elevates mouse plasma lipids.

Authors:  Lichun Zhou; Hong Yang; Xinghua Lin; Emmanuel U Okoro; Zhongmao Guo
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.